MYX
Mayne Pharma Group Ltd
Pharmaceuticals
·
Healthcare
2
comments
1
fund manager
past 90 days
About Mayne Pharma Group Ltd
Headquartered in Salisbury, Australia, and founded in 1845, Mayne Pharma Group Ltd. develops and manufactures proprietary and generic pharmaceutical products. The company operates through four segments: Generic Products, manufacturing and distributing generic and branded pharmaceuticals; Specialty Products, focusing on branded distribution; Metrics Contract Services, providing pharmaceutical contract services; and Mayne Pharma International, which manages sales, distribution, and third-party contract manufacturing in Australia. Mayne Pharma integrates these divisions to offer comprehensive pharmaceutical development and commercialization.
Commentary Volume
2
Comments
1
Fund managers
0
Past 90 days
SOURCE
ACTION
COMMENT PREVIEW
FUND MANAGER
DATE
Loading...
.
​Loading...
Loading...
Loading...
Loading...
Source: Ipsum Capital Q4 Quarterly Letter · Published 14 March 2025
Report a problem
Loading...
.
Loading...
Loading...
Loading...
Loading...
§ Important Notice
The entries below are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.
Commentary
Sector
Healthcare
Market cap
$186M
Fund managers
1 manager
First covered
22 May 2025
Last updated
10 July 2025
Company Details
Related Themes
ic
Ipsum Capital
6 comments
ic
Amet Funds
4 comments
ic
Dolor
3 comments
Top Investors Covering MIN
§ Reminder
The entries above are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.
Frequently asked questions about Mayne Pharma Group Ltd (ASX:MYX)
Frequently asked questions
Who is investing in Mayne Pharma Group Ltd (ASX:MYX)?
Fund managers including Harvest Lane Asset Management have invested in Mayne Pharma Group Ltd (ASX:MYX).
What is the short interest in Mayne Pharma Group Ltd (ASX:MYX)?
The short interest in Mayne Pharma Group Ltd (ASX:MYX) is 1.81% which makes it the 146th most shorted stock on the ASX. Of the 81.2M shares that Mayne Pharma Group Ltd has on issue, 1.5M have been sold short.
What does Mayne Pharma Group Ltd (ASX:MYX) do?
Headquartered in Salisbury, Australia, and founded in 1845, Mayne Pharma Group Ltd. develops and manufactures proprietary and generic pharmaceutical products. The company operates through four segments: Generic Products, manufacturing and distributing generic and branded pharmaceuticals; Specialty Products, focusing on branded distribution; Metrics Contract Services, providing pharmaceutical contract services; and Mayne Pharma International, which manages sales, distribution, and third-party contract manufacturing in Australia. Mayne Pharma integrates these divisions to offer comprehensive pharmaceutical development and commercialization.
Loading...